Vyome Holdings (HIND) Assets Average (2016 - 2026)
Vyome Holdings (HIND) posted quarterly Assets Average of $8.3 million for Q1 2026, up 490.61% year-over-year from $1.4 million in Q1 2025, and up 23.19% quarter-over-quarter from $6.8 million in Q4 2025.
Vyome Holdings (HIND) Assets Average (2016 - 2026) Analysis & Trends
Vyome Holdings' Assets Average history runs 11 years deep, the most recent figure standing at $8.3 million for Q1 2026.
- In Q1 2026, Assets Average rose 490.61% year-over-year to $8.3 million; the TTM figure through Mar 2026 stood at $8.3 million (up 490.61% YoY), while the FY2025 annual figure was $3.9 million, down 34.59% from the prior year.
- Assets Average for Q1 2026 stood at $8.3 million, up from $6.8 million in the prior quarter.
- The five-year high for Assets Average was $49.1 million in Q1 2022, with the low at $1.3 million in Q4 2024.
- The 5-year median for Assets Average is $9.2 million (2023), against an average of $14.3 million.
- The sharpest annual moves came in 2024 and 2026: Assets Average slumped 85.61% in 2024, then surged 490.61% in 2026.
- Vyome Holdings' Assets Average stood at $18.8 million in 2022, then sank by 50.86% to $9.2 million in 2023, then plunged by 85.61% to $1.3 million in 2024, then surged by 409.15% to $6.8 million in 2025, then rose by 23.19% to $8.3 million in 2026.
- Business Quant data shows HIND's Assets Average at $8.3 million in Q1 2026, $6.8 million in Q4 2025, and $8.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.34 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.09 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.27 Bn |
| 10 | Vyome Holdings | 16.00 Mn | 8.11 Mn | 11,658.00 | 9.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.68 Mn |
| Mar 31, 2026 | 8.34 Mn |
| Dec 31, 2025 | 6.77 Mn |
| Sep 30, 2025 | 8.04 Mn |
| Jun 30, 2025 | 5.24 Mn |
| Mar 31, 2025 | 1.41 Mn |
| Dec 31, 2024 | 1.33 Mn |
| Sep 30, 2024 | 3.84 Mn |
| Jun 30, 2024 | 7.31 Mn |
| Mar 31, 2024 | 9.45 Mn |
| Dec 31, 2023 | 9.25 Mn |
| Sep 30, 2023 | 9.84 Mn |
| Jun 30, 2023 | 14.10 Mn |
| Mar 31, 2023 | 13.75 Mn |
| Dec 31, 2022 | 18.81 Mn |
| Sep 30, 2022 | 33.42 Mn |
| Jun 30, 2022 | 42.99 Mn |
| Mar 31, 2022 | 49.08 Mn |
| Dec 31, 2021 | 71.66 Mn |
| Sep 30, 2021 | 105.40 Mn |